Cannara Biotech Inc. (TSX:LOVE)
Canada flag Canada · Delayed Price · Currency is CAD
1.840
-0.030 (-1.60%)
At close: Mar 9, 2026

Cannara Biotech Revenue

Cannara Biotech had revenue of 30.11M CAD in the quarter ending November 30, 2025, with 20.11% growth. This brings the company's revenue in the last twelve months to 112.25M, up 28.52% year-over-year. In the fiscal year ending August 31, 2025, Cannara Biotech had annual revenue of 107.20M with 31.14% growth.

Revenue (ttm)
112.25M
Revenue Growth
+28.52%
P/S Ratio
1.65
Revenue / Employee
248.33K
Employees
452
Market Cap
184.72M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Aug 31, 2025107.20M25.45M31.14%
Aug 31, 202481.75M24.49M42.77%
Aug 31, 202357.26M21.42M59.76%
Aug 31, 202235.84M18.82M110.58%
Aug 31, 202117.02M14.47M567.24%
Aug 31, 2020 Pro Pro Pro
Aug 31, 2019 Pro Pro Pro
Aug 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition